DE WILD TAMARA F.
Known title: SVP OF LEGAL & GENERAL COUNSELCIK: 0001983979
Associated companies
Transaction History
| ORLY | ▲ Buy | Option Exercise | 1,374 | $331K | 2/26/2025 | View on chart |
| ORLY | ▲ Buy | Option Exercise | 150 | $38K | 2/26/2025 | View on chart |
| ORLY | ▼ Sell | Open Market | 1,524 | $2.0M | 2/26/2025 | View on chart |
| ORLY | ▲ Buy | Option Exercise | 1,750 | $421K | 11/29/2024 | View on chart |
| ORLY | ▼ Sell | Open Market | 1,750 | $2.2M | 11/29/2024 | View on chart |
| ORLY | ▼ Sell | Gift | 82 | $102K | 11/29/2024 | View on chart |
| ORLY | ▲ Buy | Option Exercise | 2,000 | $481K | 8/15/2024 | View on chart |
| ORLY | ▼ Sell | Open Market | 2,000 | $2.3M | 8/15/2024 | View on chart |
| ORLY | ▲ Buy | Option Exercise | 1,650 | $397K | 2/28/2024 | View on chart |
| ORLY | ▼ Sell | Open Market | 1,650 | $1.8M | 2/28/2024 | View on chart |
| ORLY | ▲ Buy | Option Exercise | 549 | $148K | 2/20/2024 | View on chart |
| ORLY | ▼ Sell | Open Market | 549 | $577K | 2/20/2024 | View on chart |
| ORLY | ▲ Buy | Option Exercise | 549 | $149K | 11/10/2023 | View on chart |
| ORLY | ▼ Sell | Open Market | 549 | $542K | 11/10/2023 | View on chart |
| ORLY | ▲ Buy | Option Exercise | 549 | $115K | 8/30/2023 | View on chart |
| ORLY | ▼ Sell | Open Market | 549 | $525K | 8/30/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
ORLY Faces Earnings Watch Amid Mixed Analyst Views
Investors are watching O'Reilly Automotive ahead of its next earnings report, with questions about whether it will beat estimates again. While some analysts view the stock as a high-quality compounder at a reasonable valuation, others suggest it may be overlooked. The company is currently trading within its 52-week range, with an average analyst target of $107.35.
ORLY Faces Earnings Watch Amid Mixed Analyst Views. Investors are watching O'Reilly Automotive ahead of its next earnings report, with questions about whether it will beat estimates again. While some analysts view the stock as a high-quality compounder at a reasonable valuation, others suggest it may be overlooked. The company is currently trading within its 52-week range, with an average analyst target of $107.35.